FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3149777268> ?p ?o ?g. }

• W3149777268 endingPage "102286" @default.
• W3149777268 startingPage "102286" @default.
• W3149777268 abstract "In this study, the ability of antimicrobial photodynamic therapy (aPDT) as a treatment approach and adjuvant therapy using curcumin-poly (lactic-co-glycolic acid) nanoparticles (Cur@PLGA-NPs) to inactivate Coronavirus disease 2019 (COVID-19) in plasma was investigated. Furthermore, to verify whether the quality requirement of aPDT-treated plasma is acceptable, the differences of the levels of clotting factors, total plasma proteins, and anti-A and/or anti-B antibodies titrations in plasma of patient before and after aPDT treatment were investigated. Cur@PLGA-NPs was synthesized using Electrospinning process and characterized by different analysis including Scanning Electron Microscope (SEM), Transmission Electron Microscope (TEM), and Fourier Transform Infrared (FTIR) spectroscopy assays. The presence of the SARS-CoV-2 in the plasma samples of patients suspected of having COVID-19 was confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) assay. Then, the treated plasma samples with Cur@PLGA-NPs plus blue laser were exposed to Vero cells. Eventually, cell cytotoxicity and apoptotic effects of treated Vero cells were evaluated. Levels of clotting factors including prothrombin time (PT) and activated partial thromboplastin time (APTT), total plasma proteins, and anti-A and/or anti-B antibodies measurements were performed using the coagulometer, method of Bradford, and titration procedure, respectively. The presence of SARS-CoV-2 was positive in 84.3 % of samples. Different concentrations of Cur@PLGA-NPs (3, 5, 7, and 10 % wt.), the irradiation times of blue laser (1, 3, and 5 min), and aPDT with the maximum dosed of blue laser light (522.8 J/cm2) plus 10 % wt. Cur@PLGA-NPs had no cytotoxicity. Although there were significant cell degradation and apoptotic effects in treated Vero cells with treated plasma using 10 % wt. Cur@PLGA-NPs, and a blue laser at an energy density of 522.8 J/cm2, no visible changes in cells and apoptosis were observed following aPDT. Total plasma protein content, PT, APTT, and anti-A and/or anti-B antibodies titers showed no significant changes (P > 0.05 for all comparisons) in treated plasma as compared to untreated plasma. aPDT exhibited in vitro anti-COVID-19 activities in the treated plasma containing SARS-COV-2 without Vero cell apoptosis and any adverse effects on plasma quality in aPDT-exposed plasma." @default.
• W3149777268 created "2021-04-13" @default.
• W3149777268 creator A5002224721 @default.
• W3149777268 creator A5004077143 @default.
• W3149777268 creator A5029531777 @default.
• W3149777268 creator A5079257337 @default.
• W3149777268 creator A5080328664 @default.
• W3149777268 creator A5082049146 @default.
• W3149777268 creator A5089364014 @default.
• W3149777268 date "2021-06-01" @default.
• W3149777268 modified "2023-10-14" @default.
• W3149777268 title "Robust antimicrobial photodynamic therapy with curcumin-poly (lactic-co-glycolic acid) nanoparticles against COVID-19: A preliminary in vitro study in Vero cell line as a model" @default.
• W3149777268 cites W1459451538 @default.
• W3149777268 cites W1964893456 @default.
• W3149777268 cites W1976194786 @default.
• W3149777268 cites W2014325173 @default.
• W3149777268 cites W2017451930 @default.
• W3149777268 cites W2022512993 @default.
• W3149777268 cites W2041091989 @default.
• W3149777268 cites W2075553874 @default.
• W3149777268 cites W2082314732 @default.
• W3149777268 cites W2088617446 @default.
• W3149777268 cites W2096647256 @default.
• W3149777268 cites W2101084400 @default.
• W3149777268 cites W2128635872 @default.
• W3149777268 cites W2144630525 @default.
• W3149777268 cites W2149264566 @default.
• W3149777268 cites W2156847273 @default.
• W3149777268 cites W2277683506 @default.
• W3149777268 cites W2314158862 @default.
• W3149777268 cites W2333829629 @default.
• W3149777268 cites W2484849871 @default.
• W3149777268 cites W2547726367 @default.
• W3149777268 cites W2567355023 @default.
• W3149777268 cites W2571813825 @default.
• W3149777268 cites W2606945152 @default.
• W3149777268 cites W2756103434 @default.
• W3149777268 cites W2770666519 @default.
• W3149777268 cites W2803051237 @default.
• W3149777268 cites W2967503052 @default.
• W3149777268 cites W2991363854 @default.
• W3149777268 cites W3000244297 @default.
• W3149777268 cites W3004104100 @default.
• W3149777268 cites W3004545415 @default.
• W3149777268 cites W3007189521 @default.
• W3149777268 cites W3009288790 @default.
• W3149777268 cites W3012991084 @default.
• W3149777268 cites W3013640245 @default.
• W3149777268 cites W3020976633 @default.
• W3149777268 cites W3021161367 @default.
• W3149777268 cites W3029393188 @default.
• W3149777268 cites W3034522804 @default.
• W3149777268 cites W3049611100 @default.
• W3149777268 cites W4293247451 @default.
• W3149777268 cites W51514869 @default.
• W3149777268 doi "https://doi.org/10.1016/j.pdpdt.2021.102286" @default.
• W3149777268 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8025549" @default.
• W3149777268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33838311" @default.
• W3149777268 hasPublicationYear "2021" @default.
• W3149777268 type Work @default.
• W3149777268 sameAs 3149777268 @default.
• W3149777268 citedByCount "26" @default.
• W3149777268 countsByYear W31497772682021 @default.
• W3149777268 countsByYear W31497772682022 @default.
• W3149777268 countsByYear W31497772682023 @default.
• W3149777268 crossrefType "journal-article" @default.
• W3149777268 hasAuthorship W3149777268A5002224721 @default.
• W3149777268 hasAuthorship W3149777268A5004077143 @default.
• W3149777268 hasAuthorship W3149777268A5029531777 @default.
• W3149777268 hasAuthorship W3149777268A5079257337 @default.
• W3149777268 hasAuthorship W3149777268A5080328664 @default.
• W3149777268 hasAuthorship W3149777268A5082049146 @default.
• W3149777268 hasAuthorship W3149777268A5089364014 @default.
• W3149777268 hasBestOaLocation W31497772681 @default.
• W3149777268 hasConcept C13965031 @default.
• W3149777268 hasConcept C178790620 @default.
• W3149777268 hasConcept C185592680 @default.
• W3149777268 hasConcept C192562407 @default.
• W3149777268 hasConcept C202751555 @default.
• W3149777268 hasConcept C2778250585 @default.
• W3149777268 hasConcept C2780165375 @default.
• W3149777268 hasConcept C2781323092 @default.
• W3149777268 hasConcept C55493867 @default.
• W3149777268 hasConceptScore W3149777268C13965031 @default.
• W3149777268 hasConceptScore W3149777268C178790620 @default.
• W3149777268 hasConceptScore W3149777268C185592680 @default.
• W3149777268 hasConceptScore W3149777268C192562407 @default.
• W3149777268 hasConceptScore W3149777268C202751555 @default.
• W3149777268 hasConceptScore W3149777268C2778250585 @default.
• W3149777268 hasConceptScore W3149777268C2780165375 @default.
• W3149777268 hasConceptScore W3149777268C2781323092 @default.
• W3149777268 hasConceptScore W3149777268C55493867 @default.
• W3149777268 hasFunder F4320322670 @default.
• W3149777268 hasLocation W31497772681 @default.
• W3149777268 hasLocation W31497772682 @default.
• W3149777268 hasLocation W31497772683 @default.
• W3149777268 hasOpenAccess W3149777268 @default.
• W3149777268 hasPrimaryLocation W31497772681 @default.

• next